Xu Song

1.8k total citations
57 papers, 1.4k citations indexed

About

Xu Song is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Xu Song has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biomedical Engineering, 24 papers in Molecular Biology and 18 papers in Biomaterials. Recurrent topics in Xu Song's work include Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (17 papers) and RNA Interference and Gene Delivery (8 papers). Xu Song is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (17 papers) and RNA Interference and Gene Delivery (8 papers). Xu Song collaborates with scholars based in China, United States and South Korea. Xu Song's co-authors include Tao Gong, Zhirong Zhang, Xun Sun, Zhuoya Wan, Yao Fu, Li‐Ying Hao, Qiang Peng, Yunfeng Lin, Xueqin Wei and Xiaoru Shao and has published in prestigious journals such as Biomaterials, Oncogene and Chemical Communications.

In The Last Decade

Xu Song

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Song China 20 630 505 487 163 157 57 1.4k
Amit Singh United States 15 608 1.0× 482 1.0× 604 1.2× 218 1.3× 147 0.9× 15 1.3k
Xi Zhu China 17 857 1.4× 597 1.2× 492 1.0× 185 1.1× 234 1.5× 36 1.7k
Md. Nazir Hossen United States 21 489 0.8× 410 0.8× 403 0.8× 136 0.8× 206 1.3× 37 1.3k
Satya Siva Kishan Yalamarty United States 16 630 1.0× 538 1.1× 556 1.1× 144 0.9× 192 1.2× 26 1.5k
Alexandros Marios Sofias Germany 17 494 0.8× 505 1.0× 447 0.9× 135 0.8× 128 0.8× 32 1.2k
Jilong Wang China 21 615 1.0× 557 1.1× 543 1.1× 192 1.2× 205 1.3× 46 1.5k
Zhirong Zhong China 24 766 1.2× 350 0.7× 345 0.7× 128 0.8× 134 0.9× 59 1.7k
Pengxuan Zhao China 20 703 1.1× 492 1.0× 513 1.1× 216 1.3× 150 1.0× 30 1.5k
Chunrong Yang China 25 945 1.5× 730 1.4× 538 1.1× 205 1.3× 189 1.2× 81 1.9k

Countries citing papers authored by Xu Song

Since Specialization
Citations

This map shows the geographic impact of Xu Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Song more than expected).

Fields of papers citing papers by Xu Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Song. The network helps show where Xu Song may publish in the future.

Co-authorship network of co-authors of Xu Song

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Song. A scholar is included among the top collaborators of Xu Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Song. Xu Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yanli, Wanlu Zhao, Xu Song, et al.. (2025). Applications of Tissue-Inducing Biomaterials in Nonosseous Tissues: Evidence Map of Animal Studies. Tissue Engineering Part A. 2204535882–2204535882.
2.
3.
Yang, Gang, et al.. (2023). Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy. Cell chemical biology. 30(11). 1390–1401.e6. 16 indexed citations
4.
Guan, Wenbin, Xiangmin Zhang, Ye Sun, et al.. (2022). GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma. Molecular Carcinogenesis. 61(12). 1082–1098. 5 indexed citations
5.
Zhang, Kai, Bin Ma, Kaiyan Hu, et al.. (2022). Evidence-based biomaterials research. Bioactive Materials. 15. 495–503. 23 indexed citations
6.
Song, Xu, Zhonglan Tang, Wenbo Liu, et al.. (2022). Biomaterials and regulatory science. Journal of Material Science and Technology. 128. 221–227. 15 indexed citations
7.
Zheng, Guoliang, Liang Zhao, Jia Li, et al.. (2021). A genetically encoded fluorescent biosensor for monitoring ATP in living cells with heterobifunctional aptamers. Biosensors and Bioelectronics. 198. 113827–113827. 30 indexed citations
8.
Zhao, Ting, Lei Lei, Chenqi Guo, et al.. (2020). A new tandem peptide modified liposomal doxorubicin for tumor “ecological therapy”. Nanoscale. 12(5). 3359–3369. 18 indexed citations
9.
Zheng, Guoliang, Jiangshan Dai, Haiyan Wang, et al.. (2020). A hairpin-mediated nicking enzymatic signal amplification for nucleic acids detection. Talanta. 225. 121991–121991. 14 indexed citations
10.
Luo, Shi, Ling Guo, Lang Deng, et al.. (2020). Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis. Biomaterials. 249. 120055–120055. 75 indexed citations
11.
Xiao, Peihong, Juan Zhao, Yi Huang, et al.. (2020). A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies. Pharmaceutical Nanotechnology. 8(5). 391–398. 4 indexed citations
12.
Wan, Zhuoya, Runzi Sun, Pearl Moharil, et al.. (2020). Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. Journal of Leukocyte Biology. 109(2). 425–436. 18 indexed citations
13.
Gong, Ting, Ting Gong, Xu Song, et al.. (2019). Spontaneously formed porous structure and M1 polarization effect of Fe3O4 nanoparticles for enhanced antitumor therapy. International Journal of Pharmaceutics. 559. 329–340. 14 indexed citations
14.
Wang, Jun, Dekang Nie, Xu Song, et al.. (2019). FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling. Biochemical and Biophysical Research Communications. 517(4). 588–595. 11 indexed citations
15.
16.
Yang, Liuqing, Xu Song, Ting Gong, et al.. (2018). Development a hyaluronic acid ion-pairing liposomal nanoparticle for enhancing anti-glioma efficacy by modulating glioma microenvironment. Drug Delivery. 25(1). 388–397. 30 indexed citations
17.
Chen, Tijia, Xu Song, Ting Gong, et al.. (2017). nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy. Colloids and Surfaces B Biointerfaces. 156. 330–339. 9 indexed citations
18.
Dong, Jianxia, et al.. (2014). Subcutaneously injected ivermectin-loaded mixed micelles: formulation, pharmacokinetics and local irritation study. Drug Delivery. 23(7). 2220–2227. 19 indexed citations
19.
Shi, Qiong, Xu Song, Weijian Zhang, et al.. (2014). FRK Inhibits Migration and Invasion of Human Glioma Cells by Promoting N-cadherin/β-catenin Complex Formation. Journal of Molecular Neuroscience. 55(1). 32–41. 23 indexed citations
20.
Lin, Qing, Quan Zhang, Xu Song, et al.. (2013). Novel LC–MS/MS method for analyzing imperialine in rat plasma: Development, validation, and application to pharmacokinetics. Journal of Chromatography B. 938. 51–59. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit Singh Breakdown of academic impact, for papers by Xi Zhu Breakdown of academic impact, for papers by Md. Nazir Hossen Breakdown of academic impact, for papers by Satya Siva Kishan Yalamarty Breakdown of academic impact, for papers by Alexandros Marios Sofias Breakdown of academic impact, for papers by Jilong Wang Breakdown of academic impact, for papers by Zhirong Zhong Breakdown of academic impact, for papers by Pengxuan Zhao Breakdown of academic impact, for papers by Chunrong Yang
Rankless by CCL
2026